Abstract
To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic illnesses such as cancer and human immunodeficiency virus.
Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.
MeSH terms
-
Aging
-
Alzheimer Disease / metabolism
-
Alzheimer Disease / pathology
-
Alzheimer Disease / therapy*
-
Amyloid beta-Peptides / antagonists & inhibitors
-
Amyloid beta-Peptides / metabolism
-
Amyloid beta-Protein Precursor / metabolism
-
Animals
-
Apolipoprotein E4 / genetics
-
Apolipoprotein E4 / metabolism
-
Humans
-
Mice
-
Vitamin D / metabolism
Substances
-
Amyloid beta-Peptides
-
Amyloid beta-Protein Precursor
-
Apolipoprotein E4
-
Vitamin D